To examine how AI and telemedicine may reshape patient journeys for diabetic retinopathy, age-related macular degeneration, glaucoma, and cardiovascular risk prediction in the UK and Germany.
Key Findings:
AI has been integrated into ophthalmic screening but real-world uptake is slow and varies significantly.
The UK has a centralized health system with a strict gatekeeper model, while Germany's system is more fragmented.
Community optometrists in the UK play a crucial role in triaging patients to specialist care.
Interpretation:
Remove unsupported claims about the potential impact of AI and telemedicine.
Limitations:
The analysis is conceptual and may not capture all real-world complexities.
Differences in health system structures may limit the generalizability of findings.
Conclusion:
Revise to avoid editorial interpretations and focus on summarizing findings.
